{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:04:45Z","timestamp":1791842685543,"version":"4.3.4"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100007721","name":"Cure SMA","doi-asserted-by":"publisher","award":["EBE1819"],"award-info":[{"award-number":["EBE1819"]}],"id":[{"id":"10.13039\/100007721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007721","name":"Cure SMA","doi-asserted-by":"publisher","award":["WEL2021"],"award-info":[{"award-number":["WEL2021"]}],"id":[{"id":"10.13039\/100007721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cerebral spinal fluid (CSF) is a promising biospecimen for the detection of central nervous system biomarkers to monitor therapeutic efficacy at the cellular level in neurological diseases. Spinal muscular atrophy (SMA) patients receiving intrathecal antisense oligonucleotide (nusinersen) therapy tend to show improved motor function, but the treatment effect on cellular health remains unknown. The objective of this study was to assess the potential of extracellular RNAs and microRNAs in SMA patient CSF as indicators of neuron and glial health following nusinersen treatment. Extracellular RNA analysis of CSF samples revealed ongoing cellular stress related to inflammation and glial differentiation, even after treatment administration. Downregulated microRNA expression associated with SMA-specific or general motor neuron dysfunction in animal and cellular models, tended to increase in nusinersen-treated patient CSF samples and correlated with SMA Type 1 and 2 motor functioning improvements. However, miR-146a, known to be upregulated in SMA-induced pluripotent stem cell (iPSC)-derived astrocytes, showed increased expression in nusinersen-treated CSF samples. We then used mRNA sequencing and multi-electrode arrays to assess the transcriptional and functional effects of miR-146a on healthy and SMA iPSC-derived motor neurons. miR-146a treatment on iPSC-derived motor neurons led to a downregulation of extracellular matrix genes associated with synaptic perineuronal net and alterations in spontaneous electrophysiological activity. Altogether, this study suggests that extracellular RNAs and microRNAs may serve as useful biomarkers to monitor cellular health during nusinersen treatment. Moreover, these data highlight the importance of addressing astrocyte health and response to nusinersen in SMA pathogenesis and treatment strategies.<\/jats:p>","DOI":"10.1093\/hmg\/ddab365","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T20:11:30Z","timestamp":1639599090000},"page":"1830-1843","source":"Crossref","is-referenced-by-count":26,"title":["Assessment of cerebral spinal fluid biomarkers and microRNA-mediated disease mechanisms in spinal muscular atrophy patient samples"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-0407","authenticated-orcid":false,"given":"Emily","family":"Welby","sequence":"first","affiliation":[{"name":"Department of Cell Biology , Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J","family":"Rehborg","sequence":"additional","affiliation":[{"name":"Department of Neurology (Child Neurology) , Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Harmelink","sequence":"additional","affiliation":[{"name":"Department of Neurology (Child Neurology) , Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison D","family":"Ebert","sequence":"additional","affiliation":[{"name":"Department of Cell Biology , Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"2022060611301044100_ref1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ahg.12031","article-title":"Spinal muscular atrophy: from gene discovery to clinical trials","volume":"77","author":"Nurputra","year":"2013","journal-title":"Ann. Hum. Genet."},{"key":"2022060611301044100_ref2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0092-8674(00)81632-3","article-title":"A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing","volume":"95","author":"Pellizzoni","year":"1998","journal-title":"Cell"},{"key":"2022060611301044100_ref3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","article-title":"Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons","volume":"163","author":"Rossoll","year":"2003","journal-title":"J. Cell Biol."},{"key":"2022060611301044100_ref4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026164","article-title":"SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals","volume":"6","author":"Torres-Benito","year":"2011","journal-title":"PLoS One"},{"key":"2022060611301044100_ref5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"2022060611301044100_ref6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth","year":"2006","journal-title":"Hum. Genet."},{"key":"2022060611301044100_ref7","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2022060611301044100_ref8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"Cartegni","year":"2002","journal-title":"Nat. Genet."},{"key":"2022060611301044100_ref9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"2022060611301044100_ref10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hn RNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Hua","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"2022060611301044100_ref11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3349\/ymj.2020.61.4.273","article-title":"Nusinersen as a therapeutic agent for spinal muscular atrophy","volume":"61","author":"Li","year":"2020","journal-title":"Yonsei Med. J."},{"key":"2022060611301044100_ref12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study","volume":"29","author":"De Vivo","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"2022060611301044100_ref13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00415-019-09547-y","article-title":"Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen","volume":"267","author":"Wurster","year":"2020","journal-title":"J. Neurol."},{"key":"2022060611301044100_ref14","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1111\/jcmm.14939","article-title":"Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patients","volume":"24","author":"Faravelli","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"2022060611301044100_ref15","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1111\/jcmm.16802","article-title":"Evaluation of putative CSF biomarkers in paediatric spinal muscular atrophy (SMA) patients before and during treatment with nusinersen","volume":"5","author":"Johannsen","year":"2021","journal-title":"J. Cell. Mol. Med"},{"key":"2022060611301044100_ref16","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.779","article-title":"Neurofilament as a potential biomarker for spinal muscular atrophy","volume":"6","author":"Darras","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"2022060611301044100_ref17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jnc.14953","article-title":"Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy","volume":"153","author":"Kessler","year":"2020","journal-title":"J. Neurochem."},{"key":"2022060611301044100_ref18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-016-0053-5","article-title":"mi RNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study","volume":"5","author":"Sorensen","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"2022060611301044100_ref19","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","article-title":"MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson's disease and multiple system atrophy","volume":"54","author":"Marques","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"2022060611301044100_ref20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051714","article-title":"Circulating RNAs as potential biomarkers in amyotrophic lateral sclerosis","volume":"21","author":"Ravnik-Glavac","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"2022060611301044100_ref21","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1093\/hmg\/ddx230","article-title":"Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy","volume":"26","author":"Sison","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"2022060611301044100_ref22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.aba9763","article-title":"ANGEL2 is a member of the CCR4 family of deadenylases with 2\u2032,3\u2032-cyclic phosphatase activity","volume":"369","author":"Pinto","year":"2020","journal-title":"Science"},{"key":"2022060611301044100_ref23","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/hmg\/ddw084","article-title":"Cell-type-specific miR-431 dysregulation in a motor neuron model of spinal muscular atrophy","volume":"25","author":"Wertz","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"2022060611301044100_ref24","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/cr.2008.311","article-title":"miRNAs: small changes, widespread effects","volume":"18","author":"Linsen","year":"2008","journal-title":"Cell Res."},{"key":"2022060611301044100_ref25","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.1038\/srep12189","article-title":"Spinal muscular atrophy patient-derived motor neurons exhibit hyperexcitability","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"2022060611301044100_ref26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.celrep.2016.06.087","article-title":"A Stem Cell Model of the Motor Circuit Uncouples Motor Neuron Death from Hyperexcitability Induced by SMN Deficiency","volume":"16","author":"Simon","year":"2016","journal-title":"Cell Rep."},{"key":"2022060611301044100_ref27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13023-020-01356-1","article-title":"Longitudinal natural history of type I spinal muscular atrophy: a critical review","volume":"15","author":"Mercuri","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"2022060611301044100_ref28","first-page":"194","article-title":"Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy","volume":"24","author":"Neil","year":"2019","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"2022060611301044100_ref29","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"2022060611301044100_ref30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","article-title":"XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor","volume":"107","author":"Yoshida","year":"2001","journal-title":"Cell"},{"key":"2022060611301044100_ref31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stem.2015.08.003","article-title":"Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy","volume":"17","author":"Ng","year":"2015","journal-title":"Cell Stem Cell"},{"key":"2022060611301044100_ref32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1261\/rna.2141503","article-title":"Numerous micro RNPs in neuronal cells containing novel microRNAs","volume":"9","author":"Dostie","year":"2003","journal-title":"RNA"},{"key":"2022060611301044100_ref33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1399-0004.2010.01370.x","article-title":"microRNAs in diseases: from candidate to modifier genes","volume":"77","author":"Bandiera","year":"2010","journal-title":"Clin. Genet."},{"key":"2022060611301044100_ref34","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.47","article-title":"Altered Levels of MicroRNA-9, \u2212206, and \u2212132 in Spinal Muscular Atrophy and Their Response to Antisense Oligonucleotide Therapy","volume":"5","author":"Catapano","year":"2016","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"2022060611301044100_ref35","article-title":"Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients","volume":"8","author":"Bonanno","year":"2020","journal-title":"Biomedicine"},{"key":"2022060611301044100_ref36","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1073\/pnas.1006151107","article-title":"miRNA malfunction causes spinal motor neuron disease","volume":"107","author":"Haramati","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2022060611301044100_ref37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nn.3082","article-title":"microRNA-9 regulates axon extension and branching by targeting Map1b in mouse cortical neurons","volume":"15","author":"Dajas-Bailador","year":"2012","journal-title":"Nat. Neurosci."},{"key":"2022060611301044100_ref38","doi-asserted-by":"crossref","first-page":"20382","DOI":"10.1073\/pnas.1015691107","article-title":"microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus","volume":"107","author":"Magill","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2022060611301044100_ref39","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1126\/science.aad2509","article-title":"Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure","volume":"350","author":"Amin","year":"2015","journal-title":"Science"},{"key":"2022060611301044100_ref40","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1093\/hmg\/ddz142","article-title":"AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B\/-SMA model mice","volume":"28","author":"Kaifer","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"2022060611301044100_ref41","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1089\/omi.2018.0106","article-title":"Do perineuronal net elements contribute to pathophysiology of spinal muscular atrophy? In vitro and transcriptomics insights","volume":"22","author":"Dayangac-Erden","year":"2018","journal-title":"OMICS."},{"key":"2022060611301044100_ref42","article-title":"Astrocyte mediated MMP-9 activation in the synapse dysfunction: an implication in Alzheimer disease","volume":"1","author":"Kamat","year":"2014","journal-title":"Ther. Targets Neurol. Dis."},{"key":"2022060611301044100_ref43","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1093\/hmg\/ddn183","article-title":"Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease","volume":"17","author":"Chapuis","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"2022060611301044100_ref44","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1523\/JNEUROSCI.5210-12.2013","article-title":"Modulation of mGluR-dependent MAP1B translation and AMPA receptor endocytosis by microRNA miR-146a-5p","volume":"33","author":"Chen","year":"2013","journal-title":"J. Neurosci."},{"key":"2022060611301044100_ref45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-017-1803-x","article-title":"Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations","volume":"135","author":"Prada","year":"2018","journal-title":"Acta Neuropathol."},{"key":"2022060611301044100_ref46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pneurobio.2018.02.002","article-title":"Cell adhesion and matricellular support by astrocytes of the tripartite synapse","volume":"165-167","author":"Hillen","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"2022060611301044100_ref47","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41467-017-01624-y","article-title":"Muller glial microRNAs are required for the maintenance of glial homeostasis and retinal architecture","volume":"8","author":"Wohl","year":"2017","journal-title":"Nat. Commun."},{"key":"2022060611301044100_ref48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13229-018-0219-3","article-title":"Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders","volume":"9","author":"Nguyen","year":"2018","journal-title":"Mol. Autism."},{"key":"2022060611301044100_ref49","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1083\/jcb.122.4.915","article-title":"Neuronal growth factor regulation of two different sodium channel types through distinct signal transduction pathways","volume":"122","author":"D'Arcangelo","year":"1993","journal-title":"J. Cell Biol."},{"key":"2022060611301044100_ref50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnana.2018.00040","article-title":"Shaping synapses by the neural extracellular matrix","volume":"12","author":"Ferrer-Ferrer","year":"2018","journal-title":"Front. Neuroanat."},{"key":"2022060611301044100_ref51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"2022060611301044100_ref52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nbt.3049","article-title":"Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes","volume":"33","author":"Maury","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"2022060611301044100_ref53","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hmg\/advance-article-pdf\/doi\/10.1093\/hmg\/ddab365\/42350572\/ddab365.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/31\/11\/1830\/43949912\/ddab365.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hmg\/article-pdf\/31\/11\/1830\/43949912\/ddab365.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T11:31:18Z","timestamp":1654515078000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/31\/11\/1830\/6464690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,12,17]]},"published-print":{"date-parts":[[2022,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddab365","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2021,12,17]]}}}